Page last updated: 2024-08-23

simvastatin and Movement Disorders

simvastatin has been researched along with Movement Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cirillo, G; Tedeschi, G; Tessitore, A; Todisco, V1
Gao, K; Guo, Y; Han, D; Mei, X; Shen, Z; Song, C; Yuan, Y1
Ai, J; Chen, G; Hang, C; Qi, M; Shi, J; Zhang, S1

Other Studies

3 other study(ies) available for simvastatin and Movement Disorders

ArticleYear
Clinical reasoning: a 62-year-old man with right wrist drop.
    Neurology, 2013, Sep-10, Volume: 81, Issue:11

    Topics: Blepharoptosis; Diabetes Mellitus, Type 2; Disease Progression; Electromyography; Evoked Potentials; Fingers; Functional Laterality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Movement Disorders; Myasthenia Gravis; Simvastatin; Wrist

2013
Simvastatin inhibits neural cell apoptosis and promotes locomotor recovery via activation of Wnt/β-catenin signaling pathway after spinal cord injury.
    Journal of neurochemistry, 2016, Volume: 138, Issue:1

    Topics: Animals; Apoptosis; beta Catenin; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipopolysaccharides; Locomotion; Male; Movement Disorders; Neurons; Rats; Rats, Sprague-Dawley; Recovery of Function; Signal Transduction; Simvastatin; Spinal Cord; Spinal Cord Injuries; Time Factors; Wnt Proteins

2016
Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway.
    Experimental neurology, 2009, Volume: 216, Issue:2

    Topics: Analysis of Variance; Animals; Apoptosis; Blood-Brain Barrier; Brain Edema; Brain Injuries; Cytokines; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Intercellular Adhesion Molecule-1; Male; Movement Disorders; NF-kappa B; Rats; Rats, Wistar; Rotarod Performance Test; Signal Transduction; Simvastatin; Time Factors; Toll-Like Receptor 4

2009